GPhA Gains Medicaid/Medicare Expertise As Coster Joins As VP For Government Affairs
This article was originally published in The Pink Sheet Daily
Executive Summary
Long-time pharmacy trade association exec John Coster is tapped to head growing department.
You may also be interested in...
Patent Bill Clears Senate Judiciary Cmte. Unanimously, But Floor Fight Looms
During markup the committee adopted an amendment to remove language that set a new standard for willful infringement; other provisions affecting the pharmaceutical industry remain intact.
In Absence Of AMP Rules From CMS, Manufacturers Make Their Own
Drug manufacturers have been submitting average manufacturer price data to CMS using a new definition of AMP established by the Affordable Care Act. But they have been on their own when it comes to interpreting how to apply ACA to their calculation of AMP.
ASP Data Lag On New Generic Drugs Encourages Generic Utilization – CMS
CMS says the two-quarter lag in average sales price data for new generic drugs used for reimbursement under Medicare Part B encourages the transition from brand to generic products.